Chasteberry Plus®
Natural health product licensed in Canada
- Licence holder
- Metagenics Inc.
- NPN or DIN-HM
- 80004904
- Status
- Active licence
- Licence date
- 18 January 2008
- Revision date
- 3 September 2024
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Actaea racemosa Source : Racine Potency : 2.5 % Triterpene glycosides | 40 mg | Not calculated |
| Actaea racemosa Source : Rhizome(s) Potency : 2.5 % Triterpene glycosides | 40 mg | Not calculated |
Non-medicinal ingredients
Cellulose, microcristalline, Eau désionisée, Dioxyde de silicium, Acide stéarique, Hypromellose, Hydroxypropylcellulose, triglycérides à chaînes moyennes, Croscarmellose de sodium, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
To help relieve premenstrual symptoms.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use if you are undergoing in vitro fertilization, or have uterine, ovarian, or breast cancer. Do not use if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner. Consult your healthcare practitioner prior to use if have a liver disorder or develop symptoms of liver trouble, peptic ulcer, or an autoimmune condition. Consult a health care practitioner if symptoms persist.
Source
Official Health Canada record, licence 80004904
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging